&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-04-30, 12:00

Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars
Basil Slack

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-04-22, 12:00

Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
Bradley Crotty

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-01-31, 13:00

Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in Germany

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-01-22, 13:00

Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-03-09, 01:39

FFF Enterprises Inc. and RightNow Inventory™ Become Vital

Temecula, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., the nation’s most trusted specialty drug distributor, today announced that it...

Popular Posts